Rockefeller Capital Management
IRMD icon

Rockefeller Capital Management’s iRadimed IRMD Stock Holding History

Rockefeller Capital Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.4K Sell
119
-26
-18% -$2.37K ﹤0.01% 3966
2026
Q1 		$14K Buy
145
+20
+16% +$2K ﹤0.01% 3857
2025
Q4 		$12.2K Buy
+125
New +$10.7K ﹤0.01% 3716

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Rockefeller Capital Management's IRMD Position: Q2 2026 in Review

Rockefeller Capital Management reduced its iRadimed (IRMD) stake by 18% in Q2 2026, selling an estimated $2.37K and leaving 119 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3966.

Rockefeller Capital Management first reported a position in IRMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $14K in Q1 2026. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Rockefeller Capital Management held 119 shares of iRadimed worth $11.4K as of Q2 2026.
  • Rockefeller Capital Management sold 26 iRadimed shares in Q2 2026, an estimated $2.37K.
  • iRadimed made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3966 holding.
  • Rockefeller Capital Management first reported a position in iRadimed in Q4 2025 and has held it in 3 quarters since.
  • Rockefeller Capital Management's iRadimed position peaked at $14K in Q1 2026.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.